Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897910 · ClinicalTrials.gov registry record
Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
A clinical trial, sponsored by Barbara Ann Karmanos Cancer Institute.
- Terminated
- Registry status
- 6
- Enrollment target
NCT00897910: Clinical Trial study, sponsored by Barbara Ann Karmanos Cancer Institute.
NCT00897910 is a clinical trial that was terminated before completion, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897910 was terminated before completion, sponsored by Barbara Ann Karmanos Cancer Institute.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about T cells and plan better treatment for multiple myeloma. PURPOSE: This research study is looking at T cells in blood and bone marrow samples from patients with multiple myeloma.
Interventions
- OTHER laboratory biomarker analysis
- OTHER flow cytometry
- OTHER immunoenzyme technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-09 |
Why NCT00897910 stopped before completion
NCT00897910 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00897910 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897910 about?
NCT00897910 is a clinical study titled "Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma". RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about T cells and plan better treatment for multiple myeloma. PURPOSE: This research study is looking at T cells in blood and bone marrow samples from patients with multiple ...
What is the current status of trial NCT00897910?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2008-04. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00897910?
The interventions under investigation include: laboratory biomarker analysis (OTHER), flow cytometry (OTHER), immunoenzyme technique (OTHER).
Who is sponsoring clinical trial NCT00897910?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia